United Immunity, Co., Ltd. announced that it has raised ¥800 million in an equity round of funding on September 11, 2023. The transaction included participation from new investors, Saisei Bioventures, L.P., managed by Saisei Ventures LLC, UTEC 5 L.P., managed by returning investor, The University of Tokyo Edge Capital Partners Co., Ltd., Toho Holdings Co., Ltd. and returning investor, Ricoh Biomedical Startup Fund, managed by Venture Labo Investment. The company issued shares through third party allocation method.